Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases-Reference-Cited by-同舟云学术

Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases

Published:2018-06 Issue:5 Volume:41 Page:241-247
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Mehta Gautam U.,Malekzadeh Parisa,Shelton Thomas,White Donald E.,Butman John A.,Yang James C.,Kammula Udai S.,Goff Stephanie L.,Rosenberg Steven A.,Sherry Richard M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference16 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab;Topalian;J Clin Oncol,2014

3. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N Engl J Med,2012

4. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy;Rosenberg;Clin Cancer Res,2011

5. Randomized, prospective evaluation comparing intensity of lymphodepletion before adoptive transfer of tumor-infiltrating lymphocytes for patients with metastatic melanoma;Goff;J Clin Oncol,2016

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune responses and immunotherapeutic approaches in the treatment against cancer;Clinical & Experimental Metastasis;2024-08

2. Multiple Options: How to Choose Therapy in Frontline Metastatic Melanoma;Current Oncology Reports;2024-06-05

3. Symptomatic brain metastases in melanoma;Experimental Dermatology;2024-04

4. Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma;The Cancer Journal;2024-03

5. Biomarkers for response to TIL therapy: a comprehensive review;Journal for ImmunoTherapy of Cancer;2024-03